New insights into MS treatment
New insights into MS treatment
Data from two Novartis phase III clinical trials show that adding brain shrinkage (brain volume loss) to an existing tool to assess multiple sclerosis activity (m-Rio) will give a more precise prediction of the likelihood of future disability progression.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 3 Replies
- 1053 Views
-
Last post by jimmylegs
-
- 5 Replies
- 2237 Views
-
Last post by Jaded
-
- 0 Replies
- 3948 Views
-
Last post by NHE
-
- 0 Replies
- 8793 Views
-
Last post by NHE
-
- 0 Replies
- 2322 Views
-
Last post by NHE
-
- 0 Replies
- 2110 Views
-
Last post by Cece
-
- 0 Replies
- 1851 Views
-
Last post by frodo
-
- 2 Replies
- 1019 Views
-
Last post by NHE